Study finds correlation between certain laboratory markers and symptom burden in patients with relapsed/refractory multiple myeloma.
The immune-related AE, immune-mediated diarrhea and colitis, can have a limited course or may exist for long-term periods.
Investigators sought to determine the efficacy of using electronic PRO systems to monitor and manage symptoms in patients with advanced and metastatic cancer.
Using a self-report questionnaire, investigators sought to distinct insomnia syndrome distinct from sleep disturbance in patients with cancer.
Incorporating 2 standardized documents into the process for supportive care measures improved outcomes for patients receiving HD-MTX.
Retrospective analysis demonstrates the value in distinguishing between these conditions to salvage chemotherapy and/or targeted therapy dose in patients with cancer.
The efficacy and safety of direct oral anticoagulants and vitamin K antagonists in the treatment of ATEs/VTEs in patients with MPNs was compared.
Researchers compared adverse effect incidence with lapatinib administration at 3 different times of the day.
Risk for severe COVID-19 illness or death is lower for O versus all other groups, for Rh− versus Rh+.
This newly developed tool used several measures to successfully stratify risk of VTE in patients with hematologic cancers.